SOMU SUBRAMANIAM

Profile

First Name

: SOMU

Middle Name

:

Last Name

: SUBRAMANIAM

Related Companies
Titles
Company Name
Related People
DIRECTOR
BIOVEX GROUP, INC.
PHILIP ASTLEY-SPARKE, J. SEBASTIEN CLEIFTIE, ROBERT COFFIN, SUZETTE DUTCH, STEPHEN GORGOL, PHILIPPE GUINOT, COLIN LOVE, REENIE P. MCCARTHY, LEN POST, STEVEN PRELACK, STEPHEN REEDERS, SANDER SLOOTWEG, JAN VAN HEEK
DIRECTOR
ACHRONIX SEMICONDUCTOR CORP
ROBERT BLAKE, HOWARD BRODSKY, HOMA FIROUZTASH, JOHN LOFTON HOLT, MORGAN JONES, ANIL KHATOD, TOM LAVIN, RAJIT MANOHAR, JASON MARTIN, RICHARD SCHNEIDER, AMIT SRIVASTAVA
DIRECTOR
RF ARRAYS INC
CHANDRA DESHPANDY, THOMAS J.A. LAVIN, RUPERT PRINCE
DIRECTOR
LIGHTWIRE INC
AMEESH DIVATIA, AMIT SHAH, JAY SHAH, KALPENDU SHASTRI, SAURABH SRIVASTAVA
EXECUTIVE OFFICER
RESOLVE THERAPEUTICS LLC
PETER KIENER, JAMES POSADA
DIRECTOR
DALI SYSTEMS CO. LTD.
KAR CHEONG CHO, WEI DENG, TAYMAN KAN, ALBERT LEE, ALBERT S. LEE, KAMALJIT SANDHU, SHAWN STAPLETON, SHAWN P. STAPLETON, SOMASUNDARAM SUBRAMANIAM
DIRECTOR
TRELLIS BIOSCIENCE LLC
JAMES BRODERICK, GEOFF DILLON, STOTE ELLSWORTH, JOHN FRIEDMAN, MARKUS GOEBEL, LARRY KAUVAR, LAWRENCE KAUVAR, LAWRENCE M. KAUVAR, THOMAS LAVIN, GERALD MCMAHON, NORA MENDE, STEFAN RYSER, ELISABETH WHITNEY
DIRECTOR
BIOSCALE INC
PAUL BILLINGS, ISAAC CHENG, ISAAC S. CHENG, EDWARD CRAWLEY, EDWARD F. CRAWLEY, BILL DOYLE, WILLIAM DOYLE, WILLIAM F. DOYLE, BARD GEESAMAN, BARD J. GEESAMAN, DR. MARTIN LATTERICH, CHIP LEVEILLE, MARK LUNDSTROM, MARK E. LUNDSTROM, BRETT MASTERS, RICCARDO PIGLIUCCI, SOMU SUBRAMANIAN
DIRECTOR
SILICON SPACE TECHNOLOGY CORP
LARRY CIACCIA, DAVID DUFF, JON GWIN, FRED JORGENSEN, FREDERICK JORGENSON, BERND LIENHARD, VIVEK MOHINDRA, WESLEY H. MORRIS, WESLEY M. MORRIS, GARRY NASH, BARRY WAITE
DIRECTOR
JUVENTAS THERAPEUTICS INC
RAHUL ARAS, GEORGE ARIDA, JAMES BOLAND, SUZETTE DUTCH, GEORGE EMONT, TROY IGNELZI, JACK MINER, ROGER NEWTON, MARC PENN, MATT POLLMAN, MATTHEW POLLMAN, LINDA TUFTS
DIRECTOR
DIRECTED SENSING INC.
PETER L. FUHR, THOMAS J.A. LAVIN, VIVEK MOHINDRA, DAVID M PATTERSON
DIRECTOR
PRIVATE GROUP NETWORKS, INC.
JUDITH BENARDETE, KAI Y ENG, KAI Y. ENG, PRAMOD PANCHA
DIRECTOR
PERCEPTIMED, INC.
GRACE COLON, ROBERT E. CURRY, JOHN FRIEDMAN, ALAN JACOBS, JENNIFER JACOBS, TOM KING, THOMAS LAVIN, FRANK MAIONE, RODNEY MARKIN, HAMUTAL RUSSO, ROBERT SCHUEREN, JAMES WOODY
DIRECTOR
SVELTE MEDICAL SYSTEMS INC
DAN BOWEN, JANET BURPEE, STEVE BURPEE, MICHAEL CAPONETTO, ROBERT CROCE, RICHARD DAKERS, JACK DARBY, FERNANDO DI CAPRIO, DAVID FISCHELL, DAVID R FISCHELL, DAVID R. FISCHELL, ROBERT FISCHELL, ROBERT E FISCHELL, ROBERT E. FISCHELL, TIM A FISCHELL, TIM A. FISCHELL, ROBERT FLANAGAN, MICHAEL JOHNSON, MARK KIELEK, MARK A KIELEK, MARK A. KIELEK, TIMOTHY LASH, MARK POMERANZ, JOSEPH SMITH, MINA SOOCH, MINA P SOOCH, MINA P. SOOCH, RICHARD T SPENCER, RICHARD T. SPENCER, PHILLIP D TORRENCE, PHILLIP D. TORRENCE, NICHOLAS VALERIANI
DIRECTOR
ALEXAR THERAPEUTICS, INC.
KAMIL ALI-JACKSON, DOUGLAS GESSL, JASON HONG, RAJU MOHAN, DAVID PFEIFFER, SOMASUNDARAM SUBRAMANIAM, STEPHEN TULLMAN, NEAL WALKER
EXECUTIVE OFFICER, PROMOTER
NEW SCIENCE VENTURES FUND III, L.P.
THOMAS J.A. LAVIN
EXECUTIVE OFFICER, PROMOTER
NEW SCIENCE VENTURES FUND III (OFFSHORE), L.P.
DIRECTOR
VASCULAR THERAPIES INC
MICHAEL BAMBERGER, PAUL BARKOFSKY, ROBERT CROCE, GERALD DORROS, ROBERT FLANAGAN, SRIRAM IYER, SAMUEL M. LIANG, JOHN MCDERMOTT, ANDREW MIDLER, DAN RYAN, DANIEL RYAN, SOMUS SUBRAMANIAM, KIYOSHI TAKESUE, ALLAN TESSLER
EXECUTIVE OFFICER, PROMOTER
NSV 2016 OPPORTUNITIES FUND, L.P.
THOMAS J.A. LAVIN
EXECUTIVE OFFICER, PROMOTER
NSV 2016 OPPORTUNITIES FUND (OFFSHORE), L.P.
THOMAS J.A. LAVIN
EXECUTIVE OFFICER, PROMOTER
NSV 2017 OPPORTUNITIES FUND, L.P.
THOMAS J.A. LAVIN
DIRECTOR
RALEXAR THERAPEUTICS, INC.
KAMIL ALI-JACKSON, DOUGLAS GESSL, JASON HONG, RAJU MOHAN, DAVID PFEIFFER, SOMASUNDARAM SUBRAMANIAM, STEPHEN TULLMAN, NEAL WALKER
EXECUTIVE OFFICER, PROMOTER
NSV 2018 NEW HORIZONS FUND, L.P.
THOMAS J.A. LAVIN
EXECUTIVE OFFICER, PROMOTER
NSV 2018 OPPORTUNITIES FUND, L.P.
THOMAS J.A. LAVIN
EXECUTIVE OFFICER
NSV 2020 PREFERRED LP FUND, L.P.
THOMAS J.A. LAVIN
EXECUTIVE OFFICER
NSV GROWTH OPPORTUNITIES FUND, L.P.
THOMAS J.A. LAVIN, BRENDA MAREX
EXECUTIVE OFFICER
NSV 2021 GROWTH OPPORTUNITIES FUND, L.P.
THOMAS J.A. LAVIN
DIRECTOR
PHASE FOUR, INC.
STEWART ALSOP, JAMES BRIDENSTINE, SIMON HALPERN, BEAU JARVIS, STEPHEN KISER, ANDREW KROWNE, THOMAS J.A. LAVIN, JASON WALLACE
DIRECTOR
PAKAL TECHNOLOGIES, INC.
RICHARD BLANCHARD, BENJAMIN QUINONES, ERIC SULLIVAN, TC WU, JACKIE YANG
DIRECTOR
BRIGHTVOLT, INC
MARK ALLEN, RAJ ATLURU, CLIFTEN BEER, DAVID B. COREY, ROBERT DAIGLE, ROBERT DOYLE, FRANK EGAN, ALEX HART, ALEX W. HART, WILLIAM LESE, VIVEK MOHINDRA, CHARISSE PACHECO, CHARISSE PACHERO, JOHN PARKER, JOHN T. PETERS, JOHN TODD PETERS, JOSHUA RUCH, RONNIE SARKAR, JAMES SIMS, DAN SQUILLER, ANDREW TEICHMAN, DAN TILLWICK
DIRECTOR
ABL SPACE SYSTEMS CO
ETHAN BATRASKI, HARRISON O-HANLEY, RONALD O-HANLEY, DANIEL PIEMONT, KEVIN SAGIS
DIRECTOR
GLYDWAYS, INC.
BLAKE BARBER, PAUL FERRIS, NURIA HALTIWANGER, GOKUL HEMMADY, NAOMI ISHII, VINOD KHOSLA, MICHAEL MARASCO, MIKE MARASCO, CHRIS RILEY, SHYAM SANKAR, MARK SEEGER
DIRECTOR
FERRIC, INC.
MAURIZIO ARIENZO, YI CHEN, THOMAS DEITRICH, ALEX KALNITSKY, VIVEK MOHINDRA, LAWRENCE PILEGGI, KENNETH SHEPARD, KENNETH L. SHEPARD, NOAH STURCKEN, NOAH ANDREW STURCKEN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-07-09
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-25 
2025-09-29
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-29 
2024-12-02
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-11-20 
2024-04-30
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-04-15 
2024-01-26
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2020-12-02 
2023-12-29
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-14 
2023-08-28
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-08-11 
2023-01-26
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2020-12-02 
2022-03-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-18 
2021-12-07
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-21 
2021-10-26
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-22 
2021-07-27
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-15 
2021-07-23
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-10 
2021-05-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-23 
2021-03-18
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2021-03-05 
2021-01-04
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2020-12-02 
2020-02-14
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2020-01-31 
2019-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-11-08 
2018-10-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-01 
2018-02-01
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2018-01-17 
2018-02-01
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2018-01-17 
2017-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-15 
2017-07-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-07-21 
2017-06-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-31 
2017-02-15
D
Link
OTHER INVESTMENT FUND 
 
 
 
2017-01-31 
2016-12-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-12 
2016-07-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-07-21 
2016-07-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-28 
2016-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-28 
2016-01-19
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2016-01-08 
2016-01-04
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2015-12-18 
2015-05-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-04 
2015-04-28
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-03 
2015-03-18
D/A
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-10-28 
2015-02-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-12 
2014-09-19
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-10 
2014-07-23
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-05-30 
2014-07-23
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-05-30 
2014-07-16
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-05-30 
2014-07-16
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-05-30 
2014-06-13
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-05-30 
2014-06-13
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2014-05-30 
2014-03-12
D/A
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-10-28 
2014-01-23
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-02-01 
2014-01-23
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-13 
2014-01-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-03 
2013-11-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-31 
2013-09-19
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-06 
2013-07-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-21 
2013-05-31
D
Link
COMPUTERS 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-26 
2013-04-09
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-04-04 
2013-03-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-01-25 
2013-02-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-05 
2013-02-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-02-01 
2013-02-05
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-01-29 
2013-01-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-02 
2012-10-24
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-11 
2012-08-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-09-30 
2012-08-01
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-12 
2012-07-03
D
Link
OTHER TECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-06-22 
2012-05-23
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-11 
2012-04-25
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2012-04-09 
2012-03-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-22 
2012-02-15
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-02-03 
2012-02-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-09-30 
2011-11-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-10-27 
2011-07-27
D
Link
TELECOMMUNICATIONS 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-19 
2011-05-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-09 
2011-03-18
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-18 
2011-03-02
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-17 
2010-08-06
D/A
Link
TELECOMMUNICATIONS 
 
NOT APPLICABLE 
Equity 
2009-07-27 
2009-11-12
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2009-11-05 
2009-10-26
D
Link
TELECOMMUNICATIONS 
 
NOT APPLICABLE 
Equity 
2009-07-27 
2009-05-01
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-10-10 
2009-04-07
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2009-03-30